readthroughSign in
CompanySGMTNasdaqFoster City, CA

Sagimet Biosciences Inc.

Sagimet develops FASN inhibitors for metabolic and fibrotic diseases driven by palmitate overproduction, including acne, MASH, and FASN-dependent tumors.

SCHEDULE 13GNov 16Latest SEC filing
Nov 12Latest story